Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Foukakis

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Nature Communications|August 11, 2017
Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancerRuli Gao, Charissa Kim, Emi Sei, et al.
British Journal of Cancer|June 28, 2024
A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progressionCaroline Boman, Xingrong Liu, Louise Eriksson Bergman, et al.
Thyroid : Official Journal of the American Thyroid Association|May 1, 2007
Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma modelsJia-Jing Lee, Theodoros Foukakis, Jamileh Hashemi, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 5, 2025
Ensuring Model Fairness via Stratified Training: TP53 Mutation Prediction with Estrogen Receptor Stratification in Breast HistopathologyNikos Tsiknakis, Kang Wang, Dimitrios Salgkamis, et al.
Cancers|September 28, 2021
Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast CancerIoannis Zerdes, Vaia Karafousia, Artur Mezheyeuski, et al.
Oncoimmunology|September 20, 2018
Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancerAlexios Matikas, John Lövrot, Anna Ramberg, et al.
International Journal of Oncology|December 9, 2004
Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumorsTheodoros Foukakis, Srinivasan R Thoppe, Svetlana Lagercrantz, et al.
The Lancet Regional Health. Europe|October 13, 2025
Prevalence and prognosis of patients with breast cancer eligible for adjuvant abemaciclib or ribociclib: a nationwide population-based studyXingrong Liu, Behnaz Binicy, Balazs Acs, et al.
Breast Cancer Research : BCR|February 6, 2024
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancerCaroline Rönnlund, Emmanouil G Sifakis, Caroline Schagerholm, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2005
The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusionTheodoros Foukakis, Amy Y M Au, Göran Wallin, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Nature Communications|August 11, 2017
Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancerRuli Gao, Charissa Kim, Emi Sei, et al.
British Journal of Cancer|June 28, 2024
A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progressionCaroline Boman, Xingrong Liu, Louise Eriksson Bergman, et al.
Thyroid : Official Journal of the American Thyroid Association|May 1, 2007
Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma modelsJia-Jing Lee, Theodoros Foukakis, Jamileh Hashemi, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 5, 2025
Ensuring Model Fairness via Stratified Training: TP53 Mutation Prediction with Estrogen Receptor Stratification in Breast HistopathologyNikos Tsiknakis, Kang Wang, Dimitrios Salgkamis, et al.
Cancers|September 28, 2021
Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast CancerIoannis Zerdes, Vaia Karafousia, Artur Mezheyeuski, et al.
Oncoimmunology|September 20, 2018
Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancerAlexios Matikas, John Lövrot, Anna Ramberg, et al.
International Journal of Oncology|December 9, 2004
Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumorsTheodoros Foukakis, Srinivasan R Thoppe, Svetlana Lagercrantz, et al.
The Lancet Regional Health. Europe|October 13, 2025
Prevalence and prognosis of patients with breast cancer eligible for adjuvant abemaciclib or ribociclib: a nationwide population-based studyXingrong Liu, Behnaz Binicy, Balazs Acs, et al.
Breast Cancer Research : BCR|February 6, 2024
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancerCaroline Rönnlund, Emmanouil G Sifakis, Caroline Schagerholm, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2005
The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusionTheodoros Foukakis, Amy Y M Au, Göran Wallin, et al.
Pageof 13